When used in low doses, acetylsalicylic acid, the active substance in ASP 100, inhibits platelet aggregation. Therefore, this agent is used in situations where prevention of thromboembolic phenomena is required.
ASP 100 is indicated in situations requiring inhibition of platelet aggregation, namely: Prevention of myocardial infarction in patients with unstable angina; Acute myocardial infarction; Prevention of myocardial re-infarction; Secondary prevention of transient ischemic attacks (TIA) and thrombotic cerebrovascular accidents (CVA); Prevention of thromboembolic accidents following vascular surgery or other surgical procedures.